Latest Manufacturing News

Amotiv Limited reported modest revenue growth and a slight EBITA decline in FY25, offset by a significant non-cash impairment and strong capital returns. The company anticipates growth in FY26 amid ongoing market headwinds.

Amotiv Limited reported a modest 1% revenue increase for FY25 alongside a significant $190 million impairment, maintaining shareholder returns with a stable dividend. The company signals cautious optimism for FY26 despite ongoing market headwinds.

Amotiv Limited reported a modest 1% revenue increase to $997.4 million in FY25 but posted a net loss of $106.3 million, driven by a significant $200.4 million impairment. The company declared a fully franked final dividend of 22 cents per share and outlined strategic initiatives to navigate ongoing market challenges.

Nagambie Resources has completed a $1.2 million capital raise to fund diamond drilling at its Nagambie Mine, targeting a recent high-grade gold-antimony discovery and updating its mineral resource estimate.

Nutritional Growth Solutions Ltd has clarified discrepancies in its June 2025 quarterly reports, attributing changes to timing and classification adjustments, while reaffirming its financial health and governance compliance.

Whitebark Energy has secured independent confirmation of substantial hydrogen and helium prospective resources at its Rickerscote Prospect in South Australia's Officer Basin, highlighting a promising new frontier for clean energy minerals.

NoviqTech unveils advanced quantum-powered platforms to enhance emissions tracking and sustainability reporting across multiple industries, targeting booming carbon and recycling markets.

Lithium Universe Limited has acquired exclusive global rights to Macquarie University's innovative electrochemical silver extraction technology, promising a cleaner, more efficient way to recycle silver from solar panels while preserving valuable silicon wafers.

Anteris Technologies reported solid clinical progress with 130 patients implanted with its DurAVR heart valve and is gearing up for its pivotal PARADIGM trial with 79 qualified sites worldwide. The company also strengthened its leadership with two new board members amid ongoing FDA engagement.

Anteris Technologies Global Corp. reported a $42.7 million net loss for the first half of 2025 amid advancing preparations for its pivotal DurAVR Transcatheter Heart Valve trial. The company’s recent IPO proceeds are fueling R&D and manufacturing scale-up as it targets regulatory approvals.

Archer Materials has partnered with Belgium’s IMEC to develop a scalable, cost-effective potassium ion biosensor using silicon semiconductor technology, aiming to accelerate commercial production by late 2025.

Audeara Limited has secured a five-year licensing agreement with Eastech (Huizhou) Co., Ltd. to bring its advanced hearing technology to China’s booming medical device market, leveraging major e-commerce platforms for distribution.